Jiangsu Hengrui Medicine Co., Ltd. (600276.SS)
CNY 46.57
(-0.04%)
CNY 46.57
(-0.04%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 43.78 Billion CNY | 3.38% |
| 2022 | 42.35 Billion CNY | 7.87% |
| 2021 | 39.26 Billion CNY | 13.06% |
| 2020 | 34.72 Billion CNY | 26.03% |
| 2019 | 27.55 Billion CNY | 23.23% |
| 2018 | 22.36 Billion CNY | 23.96% |
| 2017 | 18.03 Billion CNY | 25.88% |
| 2016 | 14.33 Billion CNY | 24.64% |
| 2015 | 11.49 Billion CNY | 26.52% |
| 2014 | 9.08 Billion CNY | 25.85% |
| 2013 | 7.22 Billion CNY | 22.53% |
| 2012 | 5.89 Billion CNY | 22.3% |
| 2011 | 4.81 Billion CNY | 23.68% |
| 2010 | 3.89 Billion CNY | 29.9% |
| 2009 | 2.99 Billion CNY | 33.03% |
| 2008 | 2.25 Billion CNY | 11.95% |
| 2007 | 2.01 Billion CNY | 38.12% |
| 2006 | 1.45 Billion CNY | 13.44% |
| 2005 | 1.28 Billion CNY | 2.38% |
| 2004 | 1.25 Billion CNY | -13.46% |
| 2003 | 1.45 Billion CNY | 20.43% |
| 2002 | 1.2 Billion CNY | 7.65% |
| 2001 | 1.11 Billion CNY | 13.46% |
| 2000 | 986.27 Million CNY | 112.69% |
| 1999 | 463.7 Million CNY | 26.86% |
| 1998 | 365.52 Million CNY | 26.52% |
| 1997 | 288.91 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 46.34 Billion CNY | 5.84% |
| 2024 Q2 | 48.18 Billion CNY | 3.97% |
| 2024 Q3 | 48.33 Billion CNY | 0.33% |
| 2023 Q4 | 43.78 Billion CNY | 2.13% |
| 2023 Q1 | 42.29 Billion CNY | -0.14% |
| 2023 Q2 | 41.96 Billion CNY | -0.79% |
| 2023 FY | 43.78 Billion CNY | 3.38% |
| 2023 Q3 | 42.87 Billion CNY | 2.17% |
| 2022 Q1 | 39.81 Billion CNY | 1.4% |
| 2022 Q3 | 40.17 Billion CNY | -1.4% |
| 2022 FY | 42.35 Billion CNY | 7.87% |
| 2022 Q4 | 42.35 Billion CNY | 5.43% |
| 2022 Q2 | 40.74 Billion CNY | 2.33% |
| 2021 Q3 | 38.95 Billion CNY | 5.27% |
| 2021 Q4 | 39.26 Billion CNY | 0.81% |
| 2021 Q1 | 36.15 Billion CNY | 4.11% |
| 2021 FY | 39.26 Billion CNY | 13.06% |
| 2021 Q2 | 37 Billion CNY | 2.33% |
| 2020 Q2 | 29.67 Billion CNY | 1.75% |
| 2020 Q1 | 29.16 Billion CNY | 5.84% |
| 2020 Q3 | 32.53 Billion CNY | 9.63% |
| 2020 Q4 | 34.72 Billion CNY | 6.74% |
| 2020 FY | 34.72 Billion CNY | 26.03% |
| 2019 Q3 | 25.95 Billion CNY | 6.31% |
| 2019 Q2 | 24.41 Billion CNY | 5.31% |
| 2019 FY | 27.55 Billion CNY | 23.23% |
| 2019 Q1 | 23.18 Billion CNY | 3.67% |
| 2019 Q4 | 27.55 Billion CNY | 6.18% |
| 2018 Q1 | 18.9 Billion CNY | 4.78% |
| 2018 Q2 | 20.06 Billion CNY | 6.15% |
| 2018 Q3 | 20.8 Billion CNY | 3.67% |
| 2018 FY | 22.36 Billion CNY | 23.96% |
| 2018 Q4 | 22.36 Billion CNY | 7.5% |
| 2017 Q1 | 15.3 Billion CNY | 6.79% |
| 2017 FY | 18.03 Billion CNY | 25.88% |
| 2017 Q4 | 18.03 Billion CNY | 9.09% |
| 2017 Q3 | 16.53 Billion CNY | 5.09% |
| 2017 Q2 | 15.73 Billion CNY | 2.82% |
| 2016 Q2 | 12.73 Billion CNY | 4.33% |
| 2016 FY | 14.33 Billion CNY | 24.64% |
| 2016 Q3 | 13.63 Billion CNY | 7.06% |
| 2016 Q1 | 12.2 Billion CNY | 6.16% |
| 2016 Q4 | 14.33 Billion CNY | 5.12% |
| 2015 FY | 11.49 Billion CNY | 26.52% |
| 2015 Q4 | 11.49 Billion CNY | 5.59% |
| 2015 Q1 | 9.76 Billion CNY | 7.51% |
| 2015 Q2 | 10.23 Billion CNY | 4.79% |
| 2015 Q3 | 10.88 Billion CNY | 6.37% |
| 2014 Q1 | 7.68 Billion CNY | 6.42% |
| 2014 Q3 | 8.62 Billion CNY | 5.61% |
| 2014 Q2 | 8.16 Billion CNY | 6.27% |
| 2014 Q4 | 9.08 Billion CNY | 5.38% |
| 2014 FY | 9.08 Billion CNY | 25.85% |
| 2013 Q1 | 6.35 Billion CNY | 7.9% |
| 2013 Q2 | 6.59 Billion CNY | 3.75% |
| 2013 Q3 | 7.01 Billion CNY | 6.29% |
| 2013 Q4 | 7.22 Billion CNY | 2.98% |
| 2013 FY | 7.22 Billion CNY | 22.53% |
| 2012 Q2 | 5.35 Billion CNY | 0.99% |
| 2012 Q1 | 5.3 Billion CNY | 10.07% |
| 2012 Q4 | 5.89 Billion CNY | 4.91% |
| 2012 FY | 5.89 Billion CNY | 22.3% |
| 2012 Q3 | 5.61 Billion CNY | 4.86% |
| 2011 FY | 4.81 Billion CNY | 23.68% |
| 2011 Q4 | 4.81 Billion CNY | 1.99% |
| 2011 Q3 | 4.72 Billion CNY | 7.06% |
| 2011 Q2 | 4.41 Billion CNY | 5.38% |
| 2011 Q1 | 4.18 Billion CNY | 7.48% |
| 2010 Q2 | 3.45 Billion CNY | 4.57% |
| 2010 Q4 | 3.89 Billion CNY | 7.39% |
| 2010 FY | 3.89 Billion CNY | 29.9% |
| 2010 Q3 | 3.62 Billion CNY | 5.09% |
| 2010 Q1 | 3.3 Billion CNY | 10.07% |
| 2009 FY | 2.99 Billion CNY | 33.03% |
| 2009 Q3 | 2.73 Billion CNY | 5.15% |
| 2009 Q1 | 2.51 Billion CNY | 11.48% |
| 2009 Q2 | 2.6 Billion CNY | 3.66% |
| 2009 Q4 | 2.99 Billion CNY | 9.47% |
| 2008 Q3 | 2.13 Billion CNY | 4.44% |
| 2008 FY | 2.25 Billion CNY | 11.95% |
| 2008 Q1 | 1.99 Billion CNY | -1.01% |
| 2008 Q2 | 2.04 Billion CNY | 2.66% |
| 2008 Q4 | 2.25 Billion CNY | 5.48% |
| 2007 Q4 | 2.01 Billion CNY | 10.99% |
| 2007 Q3 | 1.81 Billion CNY | 10.1% |
| 2007 Q2 | 1.64 Billion CNY | 4.05% |
| 2007 Q1 | 1.58 Billion CNY | 8.63% |
| 2007 FY | 2.01 Billion CNY | 38.12% |
| 2006 Q1 | 1.35 Billion CNY | 5.5% |
| 2006 Q2 | 1.37 Billion CNY | 1.71% |
| 2006 Q3 | 1.4 Billion CNY | 2.17% |
| 2006 FY | 1.45 Billion CNY | 13.44% |
| 2006 Q4 | 1.45 Billion CNY | 3.48% |
| 2005 Q1 | 1.26 Billion CNY | 0.42% |
| 2005 FY | 1.28 Billion CNY | 2.38% |
| 2005 Q2 | 1.21 Billion CNY | -3.65% |
| 2005 Q3 | 1.24 Billion CNY | 2.82% |
| 2005 Q4 | 1.28 Billion CNY | 2.92% |
| 2004 Q1 | 1.32 Billion CNY | -8.71% |
| 2004 Q3 | 1.16 Billion CNY | -6.88% |
| 2004 Q4 | 1.25 Billion CNY | 7.85% |
| 2004 Q2 | 1.25 Billion CNY | -5.61% |
| 2004 FY | 1.25 Billion CNY | -13.46% |
| 2003 Q4 | 1.45 Billion CNY | 2.07% |
| 2003 Q1 | 1.29 Billion CNY | 7.26% |
| 2003 Q3 | 1.42 Billion CNY | 1.22% |
| 2003 Q2 | 1.4 Billion CNY | 8.68% |
| 2003 FY | 1.45 Billion CNY | 20.43% |
| 2002 Q2 | 1.17 Billion CNY | 0.01% |
| 2002 Q1 | 1.17 Billion CNY | 5.29% |
| 2002 FY | 1.2 Billion CNY | 7.65% |
| 2002 Q4 | 1.2 Billion CNY | 2.31% |
| 2002 Q3 | 1.17 Billion CNY | -0.08% |
| 2001 FY | 1.11 Billion CNY | 13.46% |
| 2001 Q2 | 1.04 Billion CNY | 0.0% |
| 2001 Q4 | 1.11 Billion CNY | 0.0% |
| 2000 Q4 | 986.27 Million CNY | 0.0% |
| 2000 FY | 986.27 Million CNY | 112.69% |
| 1999 FY | 463.7 Million CNY | 26.86% |
| 1998 FY | 365.52 Million CNY | 26.52% |
| 1997 FY | 288.91 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 17.08 Billion CNY | -156.343% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 11.23 Billion CNY | -289.603% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 3.27 Billion CNY | -1235.164% |
| Aurora Optoelectronics Co.,Ltd. | 2.17 Billion CNY | -1914.078% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 346.28 Million CNY | -12543.937% |
| NanJing Pharmaceutical Company Limited | 28.5 Billion CNY | -53.577% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 2.62 Billion CNY | -1565.815% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 7.77 Billion CNY | -463.408% |